Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention

Cholesteryl ester transfer protein (CETP) plays a key role in lipoprotein metabolism, and its activity has been linked to the risk of atherosclerosis (AS). CETP inhibitors, such as obicetrapib, represent a novel approach in immunotherapy to reduce the risk of atherosclerotic cardiovascular disease (...

Full description

Bibliographic Details

Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Wenhui Hu, Han Feng, Ying Liu, Xiaoshuang Xu, Ping Zhou, Zhonghua Sun, Xinyu Tao, Jiahui Yang, Jun Wu, Chen Qu, Zhengxia Liu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	CETP atherosclerosis immunotherapy inhibitor vaccination
Online Access:	https://www.tandfonline.com/doi/10.1080/21645515.2025.2462466